SCHEMBL2552176

SCHEMBL2552176

CCCCCCCCCCCCCCOC(OCCCCCCCCCCCCCC)[SiH2]CCCN

nearest known ligand 0.50

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 9/20 0.50
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TSHR P16473 1/20 0.44
EPHX1 P07099 1/20 0.44
HTT P42858 1/20 0.38
TLR2 O60603 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2555457 1.00 DNM1 (0.50) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL2552187 0.92 DNM1 (0.39) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL1862077 0.86 DNM1 (0.33) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL4539609 0.83 DNM1 (0.40) DNM1MEN1KMT2AALDH1A1HTT
SCHEMBL375556 0.83 DNM1 (0.40) DNM1MEN1KMT2AALDH1A1HTT
SCHEMBL28368332 0.82 DNM1 (0.36) DNM1MEN1KMT2ATSHRHTT
SCHEMBL28368576 0.82 DNM1 (0.36) DNM1MEN1KMT2ATSHRHTT
SCHEMBL705365 0.81 ADRB2 (0.35) DNM1ALDH1A1TSHR
SCHEMBL706696 0.81 ADRB2 (0.35) DNM1ALDH1A1TSHR
SCHEMBL703595 0.79 ADRB2 (0.36) DNM1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570899-B2 Bright silver based quaternary nanostructures SHOEI CHEMICAL INC. (JP) 2026-03-10 US disclosed
CN-115678542-B Quaternary nanostructure based on bright silver 昭荣化学工业株式会社 2024-12-31 CN disclosed
US-20240263069-A1 BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES SHOEI CHEMICAL INC. (JP) 2024-08-08 US disclosed
US-11970646-B2 Bright silver based quaternary nanostructures SHOEI CHEMICAL INC. (JP) 2024-04-30 US disclosed
CN-115678542-A Quaternary nanostructure based on bright silver 纳米系统公司 2023-02-03 CN disclosed
EP-3816247-B1 CURING MIXTURE EVONIK OPERATIONS GMBH (DE) 2022-12-07 EP disclosed
CN-113840895-B Quaternary nanostructure based on bright silver 纳米系统公司 2022-11-15 CN disclosed
US-20220228057-A1 BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES NANOSYS, INC. (US) 2022-07-21 US disclosed
EP-3973033-A1 BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES Nanosys, Inc. (US) 2022-03-30 EP disclosed
US-11254819-B2 Curing agent mixture EVONIK OPERATIONS GMBH (DE) 2022-02-22 US disclosed
EP-3078723-A1 ADDUCTS FROM ISOCYANATE OALKYLTRI METHOXYSILANES AND FLAME RETARDANTS THAT REACT WITH THEM Evonik Degussa GmbH (DE) 2016-10-12 EP disclosed
US-20160108280-A1 CROSSLINKING OF IPMS ADDUCTS WITH AMINOSILANES EVONIK DEGUSSA GMBH (DE) 2016-04-21 US disclosed
EP-2994495-A1 CROSSLINKING OF IPMS ADDUCTS AND AMINOSILANES Evonik Industries AG (DE) 2016-03-16 EP disclosed
US-9266825-B2 Copolymers of isocyanatoalkyltrialkoxysilanes and urethanediols EVONIK DEGUSSA GMBH (DE) 2016-02-23 US disclosed
EP-2905296-B1 Copolymers made of isocyanatoalkyltrialkoxysilanes and urethane diols EVONIK DEGUSSA GMBH (DE) 2015-12-23 EP disclosed
US-20150225337-A1 COPOLYMERS OF ISOCYANATOALKYLTRIALKOXYSILANES AND URETHANEDIOLS EVONIK INDUSTRIES AG (DE) 2015-08-13 US disclosed
EP-2905296-A1 Copolymers made of isocyanatoalkyltrialkoxysilanes and urethane diols Evonik Degussa GmbH (DE) 2015-08-12 EP disclosed
US-8664370-B2 Process for preparing silicon-containing azodicarbamides EVONIK DEGUSSA GMBH (DE) 2014-03-04 US disclosed
US-20130012691-A1 Process for Preparing Silicon-Containing Azodicarbamides EVONIK OPERATIONS GMBH (DE) 2013-01-10 US disclosed
WO-2011120792-A1 PROCESS FOR PREPARING SILICON-CONTAINING AZODICARBAMIDES EVONIK DEGUSSA GMBH (DE) 2011-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570899-B2 Bright silver based quaternary nanostructures LGALS3, ANXA3, ATXN2L DNM1 4621/4885MEN1 4629/4885KMT2A 1613/4885
US-20130012691-A1 Process for Preparing Silicon-Containing Azodicarbamides C1R, CA9, CCNB3 DNM1 3885/4885MEN1 381/4885KMT2A 647/4885
US-20150225337-A1 COPOLYMERS OF ISOCYANATOALKYLTRIALKOXYSILANES AND URETHANEDIOLS ACMSD, OR10J3, CCND2 DNM1 4436/4885MEN1 1137/4885KMT2A 3126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.